NovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates

  • NovoCure (NVCR) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.36 per share a year ago.